Medicure Inc. (CVE:MPH – Get Free Report)’s stock price reached a new 52-week low on Tuesday . The company traded as low as C$0.82 and last traded at C$0.82, with a volume of 500 shares traded. The stock had previously closed at C$0.83.
Medicure Stock Down 1.2 %
The company has a debt-to-equity ratio of 2.06, a quick ratio of 1.29 and a current ratio of 1.87. The stock’s 50-day moving average price is C$0.90 and its two-hundred day moving average price is C$0.97. The stock has a market capitalization of C$8.56 million, a PE ratio of -3.28 and a beta of 0.90.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Featured Stories
- Five stocks we like better than Medicure
- Learn Technical Analysis Skills to Master the Stock Market
- SAP’s Strong Momentum: A Bullish Setup for Investors
- How to Find Undervalued Stocks
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- What is the MACD Indicator and How to Use it in Your Trading
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
